Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 6, 2009, Pages 597-602

  Panetta, J D ^a   Gilani, N ^a  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CONSENSUS INTERFERON; INSULIN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BLURRED VISION; COLOR VISION; CONTROLLED STUDY; DIABETES MELLITUS; DIPLOPIA; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EYE EXAMINATION; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; PERIPHERAL VISION; PRIORITY JOURNAL; REPEAT PROCEDURE; RETINA; RETINOPATHY; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; VISUAL DISORDER; VITREOUS FLOATERS;

ADULT; AGED; ANTIVIRAL AGENTS; DIABETES MELLITUS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION; INTERFERON ALFA-2A; INTERFERONS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RETINAL DISEASES; RETROSPECTIVE STUDIES; RIBAVIRIN; RISK FACTORS;

EID: 68949200262     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04071.x     Document Type: Article

References (20)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Int Med 2006 144 : 705 14.
2. CDC. Recommendations for the prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR 1998 47 : 1 39.
3. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. American Association for the Study of Liver Diseases. Hepatology 2004 39 : 1147 71.
4. Cornberg M, Hadem J, Herrmann E, et al. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study. J Hepatol 2006 44 : 291 301.
5. Hayasaka S, Fujii M, Yamamoto Y, Noda S, Kurome H, Sasaki M. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol 1995 79 : 150 2.
6. Kawano T, Shigehira M, Uto H, et al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996 91 : 309 13.
7. Kadayifcilar S, Boyacioglu S, Kart H, Gursoy M, Aydin P. Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 1999 13 : 241 6.
8. Saito H, Ebinuma H, Nagata H, et al. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C. Liver 2001 21 : 192 7.
9. Nadir A, Amin A, Chalisa N, Van Thiel DH. Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature. J Viral Hepat 2000 7 : 466 70.
10. Manesis EK, Moschos M, Brouzas D, et al. Neurovisual impairment: A frequent complication of alpha-interferon treatment in chronic viral hepatitis. Hepatology 1998 27 : 1421 7.
11. Farel C, Suzman DL, McLaughlin M, et al. Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin. AIDS 2004 18 : 1805 9.
12. Kwon YS, Choe YH, Chin HS. Development of glaucoma in the course of interferon alpha therapy for chronic hepatitis B. Yonsei Med J 2001 42 : 134 6.
13. Kuga K, Hasumura S, Nagamori S, Toda G, Kitahara K. Intraocular hemorrhage developing during interferon therapy. Intern Med 1996 35 : 15 8.
14. Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol 2004 88 : 1518 20.
15. Schulman JA, Liang C, Kooragayala LM, King J. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003 110 : 437 42.
16. Jain K, Lam WC, Waheeb S, Thai Q, Heathcote J. Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 2001 85 : 1171 3.
17. Okuse C, Yotsuyanagi H, Nagase Y, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006 12 : 2756 3759.
18. Tsolakos A, Zalatimo N. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment. Optometry 2003 74 : 517 23.
19. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993 111 : 350 6.
20. Nagaoka T, Sato E, Takahashi A, Yokohama S, Yoshida A. Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C. Invest Ophthalmol Vis Sci 2007 48 : 368 75.